ArticleAntiviral research2016

Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.

T L Hartman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.